Combined Anticancer Treatment of Advanced Colon Cancer
Status:
Terminated
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The COMBATAC study evaluates the the effect as assessed by progression-free survival (PFS) of
perioperative systemic chemotherapy including cetuximab and cytoreductive surgery (CRS) and
bidirectional hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal
carcinomatosis arising from colorectal cancer.